Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention
January 21, 2025
Jennifer L. Schumann, Matthew Di Rago, Noel Woodford et al.
1 citation
Driving under the influence of alcohol and other drugs contributes significantly to road traffic crashes worldwide. This study explored trends of alcohol, methylamphetamine (MA), 3,4-methylenedioxy-N-methylamphetamine (MDMA) and Δ9-tetrahydrocannabinol (THC), in road crashes from 2010 to 2019 in Victoria, Australia. We conducted a cross-sectional analysis using data from the Victorian Institute...
Drug and Alcohol Review
November 1, 2024
Rebekka Syrjanen, Martin Dutch, Shaun L. Greene et al.
3 citations
Harm reduction strategies at music festivals seek to create a safer environment for patrons. The Emerging Drugs Network of Australia-Victoria (EDNAV) project is a state-wide toxicosurveillance network that derives drug intelligence from a sample of patients presenting to hospital with illicit drug-related toxicity. This publication describes the preliminary outcomes of conducting...
Journal of Analytical Toxicology
March 21, 2023
Dimitri Gerostamoulos, Linda Glowacki, Maria Pricone et al.
9 citations
Six fatalities have occurred from the ingestion of a combination of new psychoactive substances (NPSs), 4-fluoroamphetamine (4FA) and 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25C-NBOMe) over a 9-month period. Four of these fatalities (one older female and three young males) were from direct adverse effects of drugs, and one each from a fall while being intoxicated...
Forensic Science International
May 20, 2011
Jennifer L. Pilgrim, Dimitri Gerostamoulos, Noel Woodford et al.
44 citations
The use of MDMA (ecstasy) in Australia is a widespread and growing problem, promoting acute toxicity and disease which can lead to premature death in users. We report four cases of fatal serotonin toxicity caused by the combination of MDMA and moclobemide, a reversible MAO-A inhibitor with potent serotonergic activity. Despite the highly reported toxicity of this drug combination, there are...
Journal of Analytical Toxicology
May 1, 2011
Jennifer L. Pilgrim, Dimitri Gerostamoulos, Olaf H Drummer
36 citations
The increasing use of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") and tendency of users to combine MDMA with pharmaceutical agents (especially serotonergic medication) warrants a thorough understanding of MDMA's toxicity profile and potential for drug interactions. This study examined the involvement of MDMA and concurrently administered pharmaceutical drugs in cases reported to the...